Cas No.: | 75607-67-9 |
Chemical Name: | Fludarabine phosphate |
Synonyms: | Fludarabine Phosphate;9-beta-d-arabinofuranosyl-2-fluoroadenine5’-monophosphate;fludarabinemonophosphate;9-bata-d-arabinofuranosyl-2-fluoroadenine phosphate;9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE-5'-DIHYDROGEN PHOSPHATE;FLUDARUBINE PHOSPHATE;FludarabinePhosphateFdaInspected;FludarabinePhosphateUsp28;FLUDARABIN PHOSPHATE,USP30;Fludarabine (phosphate);Fludarabine 5'-Phosphate;2-Fluoro-9-(5-O-phosphono-β-D-arabinofuranosyl)-9H-purin-6-amine;2-fluoro-araamp;2-fluoro-ara-C-5'-O-phosphate;FAMP;F-ara-AMP;Fludarabin Phosphate;fludarabine;fludarabine hcl;Fludarabine Phosphate (Fludara);Fludura;9-(β-D-Arabinofuranosyl)-2-fluoroadenine 5'-Monophosphate;2-F-ara-AMP;2-Fluoroadenine 9-β-D-Arabinofuranoside 5'-Monophosphate;fludara;Fludarabine 5'-monophosphate;Oforta;2-Fluoro-ARA AMP;Fludarabine monophosphate;C10H13FN5O7P;2-Fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine;2-Fluoroadenine arabinoside 5'-monophosphate;1X9VK9O1SC;9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate;9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate;CHE |
SMILES: | O=P(O)(OC[C@H]1O[C@@H](N2C=NC3=C(N)N=C(F)N=C23)[C@@H](O)[C@@H]1O)O |
Formula: | C10H13FN5O7P |
M.Wt: | 365.2117 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis. |
In Vivo: | F-araAMP (100 mg/kg given 15 times, 167 mg/kg given 9 times, or 250 mg/kg given 3 times, i.p.) leads to complete regressions of all tumors and cures of all mice. Parental D54 tumors (i.e. without E. coli PNP) are not sensitive to treatment with F-araAMP. Intratumoral injection of Ad/PNP followed by IT F-araAMP can elicit a substantial regressive effect on otherwise refractory solid tumors in a fashion substantially superior to viral PNP transduction followed by systemic prodrug administration[1]. The comparison of ACE-GFP/fludarabine phosphate with ACE-GFP/PBS demonstrats that fludarabine phosphate alone has no growth inhibitory activity on KU-19-19 tumors[2]. |
In Vitro: | Fludarabine phosphate significantly reduces the cell viability in a dose-dependent manner. Fludarabine phosphate exhibits no effect in all tested concentrations when combined with either PBS or control vector, ACE-GFP. Fludarabine phosphate causes a significant decrease in cell viability for 24 h after exposure to ACE-PNP when compared to PBS and ACE-GFP at concentrations of 2.5, 5 and 10 μg/mL[2]. |